20.3801.19% ( +0.240 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is 11.24, below the reasonable range, cheaper than 99.1% of the time in the past 3 years, and the industry ranks 7/22, the industry Median 11.24.
11.24xP/E
HK$20.38Stock price
HK$1.81Earnings per share
11.24xP/E
Stock priceHK$20.38Earnings per shareHK$1.81
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 24.62x
- Typical range
- 14.68x–29.43x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.24x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.24x
0x4x8x12x16x20x
| Name/Symbol | |||
|---|---|---|---|
02367HKGIANT BIOGENE | 11.24x | 2.56% | HK$21.64B |
02145HKCHICMAX | 11.55x | 48.19% | HK$9.13B |
02530HKNUMANS | 11.80x | -- | HK$710.00M |
01455HKFOURACE IND GP | 10.31x | -- | HK$377.18M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
